Madunil Anuk Niriella

Prof. Madunil Anuk Niriella


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SNSiew C Ng
Siew C Ng
ZZZhirong Zeng
Zhirong Zeng
ONOla Niewiadomski
Ola Niewiadomski
WTWhitney Tang
Whitney Tang
SBSally Bell
Sally Bell
JSJoseph JY Sung
Joseph JY Sung

3 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMadunil Anuk Niriella
Madunil Anuk Niriella
DEDileepa Senajith Ediriweera
Dileepa Senajith Ediriweera
AKAnuradhani Kasturiratne
Anuradhani Kasturiratne
SSShamila Thivanshi De Silva
Shamila Thivanshi De Silva
ADAnuradha Supun Dassanayaka
Anuradha Supun Dassanayaka
HSHithanadura Janaka de Silva
Hithanadura Janaka de Silva
Background: The term “metabolic (dysfunction)-associated fatty liver disease” (MAFLD) is suggested alternative for “non-alcoholic fatty liver disease” (NAFLD), as it better reflects metabolic dysfunction. No study has compared outcomes of the two diagnostic criteria.Methods: In an ongoing, community-based, cohort-study in suburban Sri Lanka, participants were randomly selected in 2007. They were reassessed in 2014 to evaluate new-onset metabolic traits (MTs) and cardiovascular-events (CVEs). Baseline characteristics, MTs and CVEs after 7-years were compared in NAFLD and MAFLD and vs. controls. Similarly, we compared these parameters in those excluded by the NAFLD definition but captured by the MAFLD definition and vice versa, and vs. controls.Findings: Of 2985 recruited in 2007, 940 (31.5%) had NAFLD, 990 (33.1%) had MAFLD and 362 (12.1%) were controls. When compared to NAFLD, MAFLD captured an additional 2.9% and lost 1.3% individuals. At baseline, anthropometric and metabolic traits were similar in NAFLD and MAFLD. At follow-up in 7-years, the risk of having new-onset MTs and fatal/non-fatal CVEs were similar in the groups, but were significantly higher compared to controls. Those excluded by the NAFLD definition but captured by the MAFLD definition showed higher baseline MTs compared to those excluded by the MAFLD definition but captured by the NAFLD definition, and had substantially higher risk for having new-onset MTs and CVEs compared to controls.Interpretation: Although NAFLD and MAFLD had similar MTs at baseline, and similar outcomes after 7-years, those who were excluded by the NAFLD definition but captured by the MAFLD definition seem at higher risk of adverse outcomes than those excluded by the MAFLD definition but captured by the NAFLD definition. Although the increase in the index population was small, redefining NAFLD as MAFLD seemed to improve clinical utility.

11 December 2018 in Hepatology International
Verified
Journal Article
Closed access
PDF file
MNMadunil Anuk Niriella
Madunil Anuk Niriella
AKA. Kasturiratne
A. Kasturiratne
APA. Pathmeswaran
A. Pathmeswaran
SSS. T. De Silva
S. T. De Silva
KPK. R. Perera
K. R. Perera
HSH. J. de Silva
H. J. de Silva

19 March 2010 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MNMadunil Anuk Niriella
Madunil Anuk Niriella
ASArjuna P De Silva
Arjuna P De Silva
ADAsangi Hgk Dayaratne
Asangi Hgk Dayaratne
MAMadurangi Hadp Ariyasinghe
Madurangi Hadp Ariyasinghe
MNMetthanandha Mn Navarathne
Metthanandha Mn Navarathne
HSH Janaka de Silva
H Janaka de Silva
Background: Inflammatory bowel disease (IBD) is being increasingly diagnosed in Asia. However there are few epidemiological data from the region. Methods: To determine prevalence and clinical characteristics of IBD, a hospital-based survey was performed in the Colombo and Gampaha districts (combined population 4.5 million) in Sri Lanka. Patients with established ulcerative colitis (UC) and Crohn's disease (CD), who were permanent residents of these adjoining districts, were recruited from hospital registries and out-patient clinics. Clinical information was obtained from medical records and patient interviews. Results: There were 295 cases of IBD (UC = 240, CD = 55), of which 34 (UC = 30, CD = 4) were newly diagnosed during the study year. The prevalence rate for UC was 5.3/100,000 (95% CI 5.0-5.6/100,000), and CD was 1.2/100,000 (95% CI 1.0-1.4/100,000). The incidence rates were 0.69/100,000 (95% CI 0.44-0.94/100,000) for UC and 0.09/100,000 (95% CI 0.002-0.18/100,000) for CD. Female:male ratios were 1.5 for UC and 1.0 for CD. Mean age at diagnosis was (males and females) 36.6 and 38.1y for UC and 33.4 and 36.2y for CD. Among UC patients, 51.1% had proctitis and at presentation 58.4% had mild disease. 80% of CD patients had only large bowel involvement. Few patients had undergone surgery. Conclusions: The prevalence of IBD in this population was low compared to Western populations, but similar to some in Asia. There was a female preponderance for UC. UC was mainly mild, distal or left-sided, while CD mainly involved the large bowel.

3 February 2022 in Hepatology International
Verified
Journal Article
Closed access
PDF file
MKManoj Kumar
Manoj Kumar
ZAZaigham Abbas
Zaigham Abbas
MAMilad Azami
Milad Azami
MBMaria Belopolskaya
Maria Belopolskaya
ADA. K. Dokmeci
A. K. Dokmeci
YZYi-Hua Zhou
Yi-Hua Zhou

17 February 2022 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
RBRupa Banerjee
Rupa Banerjee
PPPartha Pal
Partha Pal
IHIda Hilmi
Ida Hilmi
UGUday Ghoshal
Uday Ghoshal
DDDevendra C. Desai
Devendra C. Desai
IGInflammatory Bowel Disease‐Emerging Nations' Consortium (IBD‐ENC) study group
Inflammatory Bowel Disease‐Emerging Nations' Consortium (IBD‐ENC) study group